Researchers conclude that larger, well-designed clinical trials are needed to evaluate its safety, efficacy, and potential adverse effects before clinical use can be recommended
Despite this, Novo Nordisk has been heavily advertising this medication, claiming it can help individuals lose weight and keep it off
Finally, there is growing concern regarding loss of fat-free mass (muscle) during GLP-1RA-induced weight loss, particularly in older adults or those with pre-existing sarcopenia or osteoporosis
Your PT may use visualization cues, manual techniques, or biofeedback to help retrain these muscles and support better bowel habits over time
are offering transparent pricing and bypassing traditional pharmacy benefit managers (PBMs)